return to news
  1. Cipla beats estimates for Q3 profit

Market News

Cipla beats estimates for Q3 profit

SUMMARY

Cipla, a generic drug company in India, saw a 32% increase in third-quarter profit, surpassing analysts' expectations. The growth was driven by strong performance in the North American market, with consolidated net profit reaching 10.56 billion Indian rupees. This beat the average estimate of 10.43 billion rupees.

Stock list

Cipla logo

Cipla posted a bigger-than-expected 32% rise in third-quarter profit

Next Story